Press Release-10-092, NRC Announces Selection of New Member of the Advisory Committee on Medical Uses of Isotopes: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
Line 19: Line 19:


=Text=
=Text=
{{#Wiki_filter:NRC ANNOUNCES SELECTION OF NEW MEMBER OF THE ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES The Nuclear Regulatory Commission announced the selection of John H. Suh, M.D., as one of the radiation oncologist representatives on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). The ACMUI was established in 1958 and advises the NRC on policy and technical issues related to the regulation of the medical use of radioactive material.
{{#Wiki_filter:NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs        Telephone: 301/415-8200 Washington, D.C. 20555-0001 E-mail: opa.resource@nrc.gov Site: http://www.nrc.gov No. 10-092                                                                                  May 25, 2010 NRC ANNOUNCES SELECTION OF NEW MEMBER OF THE ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES The Nuclear Regulatory Commission announced the selection of John H. Suh, M.D., as one of the radiation oncologist representatives on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). The ACMUI was established in 1958 and advises the NRC on policy and technical issues related to the regulation of the medical use of radioactive material.
Dr. Suh received his bachelor's and medical degrees from the University of Miami Miller School of Medicine in Miami, Fla. He completed his internship, residency and fellowship at the Cleveland Clinic in Ohio and joined the staff where he specialized in neuro-oncology and stereotactic radiosurgery and became the residency director in the Department of Radiation Oncology.  
Dr. Suh received his bachelors and medical degrees from the University of Miami Miller School of Medicine in Miami, Fla. He completed his internship, residency and fellowship at the Cleveland Clinic in Ohio and joined the staff where he specialized in neuro-oncology and stereotactic radiosurgery and became the residency director in the Department of Radiation Oncology.
During his tenure with the Cleveland Clinic, Dr. Suh served as clinical director for the Department of Radiation Oncology, director of the Cleveland Clinic Gamma Knife Center, chair of the Department of Radiation Oncology at the Cleveland Clinic Taussig Cancer Institute, and associate director of the Gamma Knife Center at the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic. He is board certified in radiation oncology and currently serves as the section head for the central nervous system/pediatric section for the American Board of Radiologys oral board examination.
Dr. Suhs awards have included the National Brain Tumor Foundation Clinical Research Award, Teacher of the Year Award, and selection as one of Americas Top Physicians for Cancer. He was the principal investigator for two phase III trials testing a radiation sensitizer with whole brain radiation therapy for patients with brain metastases.
Dr. Suhs patient care, research and teaching interests include adult and pediatric brain tumors, Gamma Knife radiosurgery, and innovative radiation approaches. He has authored over 120 publications and has served as the institutional principal investigator for the Radiation Therapy Oncology Group at the Cleveland Clinic since 1995. Dr. Suh has lectured extensively


During his tenure with the Cleveland Clinic, Dr. Suh served as clinical director for the Department of Radiation Oncology, director of the Cleveland Clinic Gamma Knife Center, chair of the Department of Radiation Oncology at the Cleveland Clinic Taussig Cancer Institute, and associate director of the Gamma Knife Center at the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic. He is board certified in radiation oncology and currently serves as the section head for the central nervous system/pediatric section for the American Board of Radiology's oral board examination. 
locally, nationally and internationally. He serves as a reviewer for a number of medical journals and is a member of many professional societies.
 
                                                        ###
Dr. Suh's awards have included the National Brain Tumor Foundation Clinical Research Award, Teacher of the Year Award, and selection as one of America's Top Physicians for Cancer. He was the principal investigator for two phase III trials testing a radiation sensitizer with whole brain radiation therapy for patients with brain metastases.
News releases are available through a free listserv subscription at the following Web address:
Dr. Suh's patient care, research and teaching interests include adult and pediatric brain tumors, Gamma Knife radiosurgery, and innovative radiation approaches. He has authored over 120 publications and has served as the instituti onal principal investigator for the Radiation Therapy Oncology Group at the Cleveland Clinic since 1995. Dr. Suh has lectured extensively NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs              Telephone: 301/415-8200 Washington, D.C. 20555-0001 E-mail: opa.resource@nrc.gov Site: http://www.nrc.gov No. 10-092 May 25, 2010 locally, nationally and internationally. He serves as a reviewer for a number of medical journals and is a member of many professional societies.  
http://www.nrc.gov/public-involve/listserver.html. The NRC homepage at www.nrc.gov also offers a SUBSCRIBE link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.}}
### News releases are available through a free listserv subscription at the following Web address: http://www.nrc.gov/public-involve/listserver.html. The NRC homepage at www.nrc.gov also offers a SUBSCRIBE link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.}}

Revision as of 18:45, 13 November 2019

Press Release-10-092: NRC Announces Selection of New Member of the Advisory Committee on Medical Uses of Isotopes
ML101450277
Person / Time
Issue date: 05/25/2010
From:
Office of Public Affairs
To:
References
Press Release-10-092
Download: ML101450277 (2)
v • d • e


Text

NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs Telephone: 301/415-8200 Washington, D.C. 20555-0001 E-mail: opa.resource@nrc.gov Site: http://www.nrc.gov No.10-092 May 25, 2010 NRC ANNOUNCES SELECTION OF NEW MEMBER OF THE ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES The Nuclear Regulatory Commission announced the selection of John H. Suh, M.D., as one of the radiation oncologist representatives on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). The ACMUI was established in 1958 and advises the NRC on policy and technical issues related to the regulation of the medical use of radioactive material.

Dr. Suh received his bachelors and medical degrees from the University of Miami Miller School of Medicine in Miami, Fla. He completed his internship, residency and fellowship at the Cleveland Clinic in Ohio and joined the staff where he specialized in neuro-oncology and stereotactic radiosurgery and became the residency director in the Department of Radiation Oncology.

During his tenure with the Cleveland Clinic, Dr. Suh served as clinical director for the Department of Radiation Oncology, director of the Cleveland Clinic Gamma Knife Center, chair of the Department of Radiation Oncology at the Cleveland Clinic Taussig Cancer Institute, and associate director of the Gamma Knife Center at the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic. He is board certified in radiation oncology and currently serves as the section head for the central nervous system/pediatric section for the American Board of Radiologys oral board examination.

Dr. Suhs awards have included the National Brain Tumor Foundation Clinical Research Award, Teacher of the Year Award, and selection as one of Americas Top Physicians for Cancer. He was the principal investigator for two phase III trials testing a radiation sensitizer with whole brain radiation therapy for patients with brain metastases.

Dr. Suhs patient care, research and teaching interests include adult and pediatric brain tumors, Gamma Knife radiosurgery, and innovative radiation approaches. He has authored over 120 publications and has served as the institutional principal investigator for the Radiation Therapy Oncology Group at the Cleveland Clinic since 1995. Dr. Suh has lectured extensively

locally, nationally and internationally. He serves as a reviewer for a number of medical journals and is a member of many professional societies.

News releases are available through a free listserv subscription at the following Web address:

http://www.nrc.gov/public-involve/listserver.html. The NRC homepage at www.nrc.gov also offers a SUBSCRIBE link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.

Retrieved from "https://kanterella.com/w/index.php?title=Press_Release-10-092,_NRC_Announces_Selection_of_New_Member_of_the_Advisory_Committee_on_Medical_Uses_of_Isotopes&oldid=2132613"